Inspire Medical Systems (INSP) Competitors $158.43 -1.50 (-0.94%) As of 04/30/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSP vs. SNN, SOLV, PEN, STVN, GKOS, NARI, BLCO, SLNO, IRTC, and TMDXShould you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Smith & Nephew (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Inspire Medical Systems vs. Smith & Nephew Solventum Penumbra Stevanato Group Glaukos Inari Medical Bausch + Lomb Soleno Therapeutics iRhythm Technologies TransMedics Group Inspire Medical Systems (NYSE:INSP) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings, dividends and community ranking. Does the MarketBeat Community believe in INSP or SNN? Smith & Nephew received 254 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. However, 61.71% of users gave Inspire Medical Systems an outperform vote while only 54.16% of users gave Smith & Nephew an outperform vote. CompanyUnderperformOutperformInspire Medical SystemsOutperform Votes19561.71% Underperform Votes12138.29% Smith & NephewOutperform Votes44954.16% Underperform Votes38045.84% Do analysts prefer INSP or SNN? Inspire Medical Systems currently has a consensus target price of $218.90, suggesting a potential upside of 38.17%. Smith & Nephew has a consensus target price of $27.00, suggesting a potential downside of 3.57%. Given Inspire Medical Systems' stronger consensus rating and higher possible upside, equities analysts plainly believe Inspire Medical Systems is more favorable than Smith & Nephew.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70Smith & Nephew 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is INSP or SNN more profitable? Inspire Medical Systems has a net margin of 6.67% compared to Smith & Nephew's net margin of 0.00%. Inspire Medical Systems' return on equity of 8.19% beat Smith & Nephew's return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems6.67% 8.19% 7.09% Smith & Nephew N/A N/A N/A Does the media refer more to INSP or SNN? In the previous week, Inspire Medical Systems had 5 more articles in the media than Smith & Nephew. MarketBeat recorded 14 mentions for Inspire Medical Systems and 9 mentions for Smith & Nephew. Inspire Medical Systems' average media sentiment score of 1.45 beat Smith & Nephew's score of 0.70 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 12 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, INSP or SNN? Inspire Medical Systems has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Which has stronger earnings & valuation, INSP or SNN? Smith & Nephew has higher revenue and earnings than Inspire Medical Systems. Smith & Nephew is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M5.87$53.51M$1.7391.58Smith & Nephew$5.81B2.11$263M$2.1612.96 Do institutionals and insiders believe in INSP or SNN? 94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 25.6% of Smith & Nephew shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by company insiders. Comparatively, 1.0% of Smith & Nephew shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryInspire Medical Systems beats Smith & Nephew on 14 of the 18 factors compared between the two stocks. Get Inspire Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INSP vs. The Competition Export to ExcelMetricInspire Medical SystemsSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$4.71B$4.38B$5.57B$18.97BDividend YieldN/A39.98%5.11%4.03%P/E Ratio91.5830.6722.4232.71Price / Sales5.8754.91394.1027.84Price / Cash104.4151.0838.1817.53Price / Book6.816.116.774.47Net Income$53.51M$68.15M$3.22B$1.02B7 Day Performance6.72%1.41%3.25%2.26%1 Month Performance0.97%-4.21%0.01%-2.86%1 Year Performance-34.44%24.42%18.00%5.48% Inspire Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INSPInspire Medical Systems4.8541 of 5 stars$158.43-0.9%$218.90+38.2%-34.4%$4.71B$802.80M91.58760Upcoming EarningsSNNSmith & Nephew1.966 of 5 stars$25.71-0.8%$27.00+5.0%+16.0%$11.24B$5.81B11.9020,100News CoverageGap UpSOLVSolventum1.4971 of 5 stars$64.08-3.3%$79.86+24.6%+1.8%$11.09B$8.25B23.3022,000Upcoming EarningsAnalyst ForecastPositive NewsPENPenumbra4.0749 of 5 stars$270.53-2.5%$293.93+8.7%+48.9%$10.47B$1.19B795.683,900Insider TradeAnalyst RevisionSTVNStevanato Group1.1704 of 5 stars€21.65-1.0%N/A-25.8%$6.56B$1.10B46.064,650Positive NewsGap DownGKOSGlaukos4.7642 of 5 stars$88.17-2.3%$156.17+77.1%-1.7%$4.99B$383.48M-30.72780Earnings ReportNews CoverageGap DownNARIInari MedicalN/A$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800BLCOBausch + Lomb3.8493 of 5 stars$12.05-0.1%$18.82+56.2%-20.4%$4.26B$4.79B-13.2412,500Earnings ReportNews CoverageGap DownSLNOSoleno Therapeutics4.6454 of 5 stars$68.93-1.5%$99.63+44.5%+67.6%$3.16BN/A-20.7630Upcoming EarningsPositive NewsIRTCiRhythm Technologies0.9812 of 5 stars$98.63-2.3%$119.73+21.4%-2.5%$3.10B$591.84M-27.101,790News CoveragePositive NewsTMDXTransMedics Group3.1986 of 5 stars$87.72-0.6%$122.70+39.9%-2.3%$2.97B$441.54M93.32210Upcoming EarningsAnalyst ForecastGap Down Related Companies and Tools Related Companies Smith & Nephew Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Inari Medical Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives iRhythm Technologies Alternatives TransMedics Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INSP) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INSP Stock Free INSP Stock Alerts